9-(2-chlorophenethyl)-6-[(2-chlorophenethyl)thio]-9H-purine

ID: ALA4763745

PubChem CID: 162661176

Max Phase: Preclinical

Molecular Formula: C20H16Cl2N4S

Molecular Weight: 415.35

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Clc1ccccc1CCSc1ncnc2c1ncn2Cc1ccccc1Cl

Standard InChI:  InChI=1S/C20H16Cl2N4S/c21-16-7-3-1-5-14(16)9-10-27-20-18-19(23-12-24-20)26(13-25-18)11-15-6-2-4-8-17(15)22/h1-8,12-13H,9-11H2

Standard InChI Key:  IBAQPXBXKVTMDO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   23.1234  -26.1501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1223  -26.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8303  -27.3786    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8286  -25.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5372  -26.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5420  -26.9651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3220  -27.2135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7994  -26.5484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3143  -25.8890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8261  -24.9240    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.1172  -24.5176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4107  -24.9283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7018  -24.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7029  -23.7054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9948  -23.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2874  -23.7098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2924  -24.5312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0011  -24.9339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0072  -25.7511    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   25.5790  -27.9893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3793  -28.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6312  -28.9303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4306  -29.0957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9748  -28.4849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7140  -27.7060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9151  -27.5442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0859  -29.5389    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
  7 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 22 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4763745

    ---

Associated Targets(Human)

DBF4 Tbio CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) (451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 415.35Molecular Weight (Monoisotopic): 414.0473AlogP: 5.52#Rotatable Bonds: 6
Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.05CX LogP: 5.99CX LogD: 5.99
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.31Np Likeness Score: -1.53

References

1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A.  (2021)  Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis.,  210  [PMID:33139113] [10.1016/j.ejmech.2020.112968]

Source